Do low morning cortisol and low DHEA-S reflect reduced adrenal output and HPA-axis dysregulation?

Clinical indicators of adrenal hypofunction

• Early-morning serum cortisol is the primary clinical biomarker for assessing hypothalamic-pituitary-adrenal (HPA) axis activity, where levels falling below 3–5 µg/dL indicate adrenal hypofunction.
• Because dehydroepiandrosterone sulfate (DHEA-S) is synthesized in the adrenal zona reticularis and has a long half-life, low circulating levels (typically <25–50 µg/dL) directly reflect diminished adrenal androgen output.
• Joint suppression of both markers represents a clinically validated endocrine pattern of reduced adrenal steroidogenesis, pointing to disrupted pituitary-adrenal signaling and functional HPA-axis insufficiency.

Mechanistic links to fluctuating energy

• Cortisol and DHEA-S function as metabolic and physiological counterweights to regulate daily energy cycles. Cortisol normally peaks shortly after waking to mobilize glucose and sustain diurnal activity, while DHEA-S acts as an anabolic buffer to promote recovery.
• Under chronic stress, HPA-axis dysregulation often manifests as an altered cortisol:DHEA-S ratio, a blunted cortisol awakening response, and a flattened diurnal cortisol slope.
• This suppressed, flat daily endocrine signature impairs morning energy mobilization and deprives the body of anabolic protection, directly correlating with severe physical fatigue, highly fluctuating energy levels, and poor stress recovery.

Bottom line

• Concurrent low morning cortisol and low DHEA-S serve as clear biomarkers of reduced adrenal steroid output and HPA-axis dysregulation, which clinically drives disrupted diurnal rhythms and persistent fluctuations in daily energy.